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Abstract
Background: Rosemary (Rosmarinus officinalis L.) extracts (REs) exhibit hepatoprotective, anti-obesity and anti-inflammatory
properties and are widely used in the food industry. REs are rich in carnosic acid (CA) and carnosol which may be
responsible for some of the biological activities of REs. The aim of this study was to investigate whether inhibition of lipase
activity in the gut may be a mechanism by which a RE enriched in CA (40%) modulates body weight and lipids levels in a rat
model of metabolic disorders and obesity.
Methods and Principal Findings: RE was administered for 64 days to lean (fa/+) and obese (fa/fa) female Zucker rats and
body weight, food intake, feces weight and blood biochemical parameters were monitored throughout the study. Lipase
activity (hydrolysis of p-nitrophenylbutyrate) was measured in the gastrointestinal tract at the end of the study and the
contents of CA, carnosol and methyl carnosate were also determined. Sub-chronic administration of RE moderately reduced
body weight gain in both lean and obese animals but did not affect food intake. Serum triglycerides, cholesterol and insulin
levels were also markedly decreased in the lean animals supplemented with RE. Importantly, lipase activity was significantly
inhibited in the stomach of the RE-supplemented animals where the highest content of intact CA and carnosol was
detected.
Conclusions: Our results confirm that long-term administration of RE enriched in CA moderates weight gain and improves
the plasma lipids profile, primarily in the lean animals. Our data also suggest that these effects may be caused, at least in
part, by a significant inhibition of gastric lipase and subsequent reduction in fat absorption.
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Introduction
Obesity is a global health issue resulting from a combination of
high-energy diets, sedentary lifestyles and genetic make-up and is
accompanied by a cluster of chronic metabolic diseases which
include cardiovascular diseases (CVDs), hypertension, type-2
diabetes and non-alcoholic steatohepatitis. The incidence and
impact of these major health threats have risen to alarming
proportions in Western societies and there is a great need for
therapeutic and preventive measures [1]. The pharmaceutical
industry has invested efforts and resources in producing anti-
obesity drugs such as lipid digestion inhibitors; however, only an
inhibitor obtained from actinobacterium, orlistat, is currently
approved and authorized in Europe for obesity treatment [2].
Obesity and metabolic disorders are characterized by an
excessive weight due to enlarged fat deposition and by an
associated chronic inflammation. Since current medical treatments
often fail to stop the progress of these diseases, polyphenol-rich
foods or derived by-products with anti-inflammatory properties
are being widely investigated as a potential additional strategy to
combat obesity [1]. Numerous published studies have evaluated
the anti-obesity properties of polyphenols. Like this, an orange
juice containing anthocyanins, flavanones and cinnamic acids has
been shown to reduce body weight and fat accumulation in a
mouse model of obesity [3]. More recently, it has been reported
that an aqueous roiboos extract rich in polyphenols reduced the
levels of cholesterol, TGs and fatty acids as well as liver steatosis in
hyperlipidemic mice [4]. The mechanisms by which polyphenols
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may exert these anti-obesity effects are only beginning to emerge
and may involve a combination of multiple molecular effects such
as modulation of metabolic-, antioxidant-, and anti-inflammatory-
gene and protein expression [1].
Rosmarinus officinalis L (Lamiaceae) is a plant widely distributed
in Europe, Asia and Africa much utilized in the food industry for
its functional properties as well as for its beneficial health
properties. The biological activities of the plant have been
attributed to two groups of compounds: the volatile fraction and
the phenolic compounds. This latter group mainly contains a
flavonoid fraction, rosmarinic acid, and some diterpenoid com-
pounds structurally derived from CA, e.g. carnosol, rosmanol, etc.
The most abundant compounds, CA and rosmarinic acid, exhibit
a wide range of activities, including antioxidant, anti-inflammatory
and hepatoprotective effects [5]. Currently, considerable scientific
interest is directed toward the effects of REs on obesity and
obesity-related diseases. Rosemary leaf extracts and CA have been
shown to reduce body weight, fat mass gain and serum lipids levels
in male mice fed a high-fat diet [6,7] and in a leptin-deficient (ob/
ob) male mouse model [8]. Since REs, CA and carnosol have been
shown to inhibit porcine pancreatic lipase in vitro [6,7,9], the
reported anti-obesity effects of rosemary have been attributed to
the inhibition of this activity [6,8].
To gain further insight in the mechanisms by which REs and
(or) CA may exert their anti-obesity properties, we have
determined the lipase activity in the gut, liver and pancreas of
obese (fa/fa) leptin receptor-deficient female Zucker rats and their
lean (fa/+) counterparts following long-term administration of a
RE highly enriched in CA (40%). The effects of the RE on body
weight, food intake, biochemical blood parameters and liver lipids
were analyzed and compared between the obese and the lean
animals. In addition, we have determined and quantified the
presence and content of CA, carnosol and methyl carnosate in
these organs.
Materials and Methods
Materials
The RE used in this study (reference GAX00011 batch number
A273/045/A10) was kindly provided by Naturex (Valencia, Spain)
and was prepared according to a patented method [10] as follows:
rosemary leaves were extracted with 96% ethanol at room
temperature and the ethanolic extract was filtered and concen-
trated under reduced pressure at 45uC to make a concentrated
native extract. The native extract was then diluted with aqueous
sodium bicarbonate (NaHCO3) at pH 8.5–9 to dissolve CA and
other organic acids, while other substances insoluble in alkaline
conditions were precipitated out. The solution was filtered and the
filtrate further concentrated under reduced pressure. The
concentrated solution was then acidified with phosphoric acid
(H3PO4) to pH 4.9 to precipitate the acid insoluble substances
including CA, carnosol and CA derivatives. The solid precipitate
was subsequently washed with water and filtered to remove
impurities. The purified solid product was finally dried in a
vacuum oven and milled into powder. CA and carnosol standards
were purchased from Sigma-Aldrich S.A. (Madrid, Spain).
Methanol (MeOH), acetone and acetonitrile (ACN) were obtained
from Merck (Darmstadt, Germany). Milli-Q system (Millipore,
USA) ultrapure water was used throughout the study. All other
chemicals were of analytical grade.
Animals and Experimental Design
Fourteen female Zucker lean (fa/+) (Le) and 10 obese (fa/fa)
(Ob) rats aged 5 weeks (105.5613.3 g and 148.5622.9 g,
respectively) were purchased from Harlan Laboratories Models
S.L. (Barcelona, Spain). This study was carried out at the
Experimental Animal Facility of the University of Murcia (Spain;
Registration number: REG A ES 300305440012) in strict
accordance with the recommendations of the European Union
regarding animal experimentation (Directive of the European
Council 86/609/EC). The protocol was approved by the local
animal ethics committee and the local government (Murcia
Autonomous Government of Agriculture, Fisheries and Livestock,
Permit Number: C1311031102). Rats were housed 2–4 to a cage in a
room with controlled temperature (2262uC), 55%610% relative
humidity, and a 12 h light-dark cycle. They were fed with a
standard chow (composition: 14.3% protein, 4.0% fat, 48.0%
carbohydrate, 4.1% crude fiber, 18.0% neutral detergent fiber and
4.7% ash; energy density, 2.9 kcal/g) for several days before the
start of the experiments. Animals were randomly assigned to two
experimental groups: i) control groups (CTLe, n = 7 and CTOb,
n = 5) fed with the standard chow alone and ii) treated groups
(RELe n = 7 and REOb, n = 5) fed with the standard chow
supplemented with RE (0.5% w/w). Diet and tap water were
administered ad libitum. Dietary intervention lasted for 64 days.
Body weight, feces weight and food and water intake were
recorded throughout the study. At the end of the experimental
period, non-fasting animals were anaesthetized by intramuscular
injection with a mixture (1:1, v/v; 1 mL/kg of body weight) of
ketamine (Imalgene 1000; Merial Laboratories, Barcelona, Spain)
and xylazine (Xilagesic 2%; Calier Laboratories, Barcelona, Spain)
and sacrificed by heart puncture exsanguination. All efforts were
made to minimize suffering. Liver, pancreas as well as the contents
of stomach, duodenum (first 10 cm of the small intestine), and
small intestine (jejunum+ileum) were rapidly taken, weighed,
frozen in liquid nitrogen and stored at 280uC until further
analysis.
Sample preparation for the analysis of phenolic
compounds
Fresh solutions of RE were prepared by dissolving 0.1 g of the
powder in 2.0 mL of ACN (1 h, 40uC). The solution was further
diluted (1/50) with ACN and filtered (0.45 mm) prior to injection
(20 mL) into the HPLC-DAD-MS/MS system. Pancreas and liver
samples (,0.5 g) were vigorously homogenized with 2.5 mL of
MeOH/water/HCl (79.9:20:0.1) using an IKA T10 Ultra-Turrax
(Janke & Kunkel, Ika-Labortechnick, Germany) at 24000 rpm
(4uC) for 1 min and then exposed to ultrasound for 10 min. The
mixture was centrifuged (Eppendorf 5804R, Eppendorf AG,
Hamburg, Germany) at 2880 g (4uC) for 5 min. The methanolic
phase was evaporated in a SpeedVac concentrator (Savant
SPD121P, Thermo Scientific, Alcobendas, Spain) equipped with
a refrigerated vapor trap RVT4104 (Thermo Scientific, Alcoben-
das, Spain) and a vacuum pump v-710 (BU¨CHI Labortechnik AG,
Postfach, Switzerland), then diluted with 200 mL of MeOH and
filtered (0.45 mm) prior to injection (20 mL) to the HPLC-DAD-
MS/MS system. Gut contents (50–500 mg) were also homoge-
nized with cold MeOH/water/HCl (50:49.9:0.1) (0.3–1.5 mL)
using an IKA T10 Ultra-Turrax (Janke and Kunkel, Ika-
Labortechnick, Germany) at 24000 rpm at 4uC for 1 min and
then exposed to ultrasound for 10 min. The mixture was then
centrifuged at 2880 g at 4uC for 5 min and the supernatant kept at
4uC. Each pellet was extracted twice with the same methanolic
solution. Both supernatants were pooled, filtered (0.45 mm) and
injected (20 mL) into the HPLC-DAD-MS-MS system.
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HPLC-DAD-MS/MS analyses
Analyses of the phenolic compounds present in the RE and in
the different organs and gastrointestinal contents were performed
on an Agilent 1100 HPLC system equipped with a photodiode-
array detector and an ion-trap mass spectrometer detector in series
(Agilent Technologies, Waldbronn, Germany). Chromatographic
separation was carried out on a reversed phase Mediterranean
C18 column (4.66250 mm, 5 mm particle size) (Tecknokroma,
Barcelona, Spain), operating at room temperature and using
water/formic acid (99:1, v/v) (phase A) and ACN (phase B) at a
flow rate of 0.5 mL/min. The gradient was as follows: 0–10 min,
10%–70% B; 10–45 min, 70%–90% B; 45–46 min 90–98% B;
46–50 min; 98–10% B. Finally, the column was re-equilibrated for
5 min. The ion-trap mass spectrometer was equipped with an
electrospray ionization system (ESI, capillary voltage, 4 kV).
Nitrogen was used as nebulizer gas at a pressure of 65 psi and
as dry gas at a flow rate and temperature of 9 L/min and 350uC,
respectively. Mass scan (MS) and MS/MS daughter spectra were
operated in negative ionization mode with a mass scan range from
m/z 100 to 800. Collision-induced fragmentation experiments
were performed in the ion trap using helium as collision gas with
collision energy of 1V. UV chromatograms were recorded at 285,
330 and 360 nm. The different compounds and metabolites were
identified according to their UV spectra, molecular weight and
MS-MS fragments. In addition, CA and carnosol were quantified
in the rosemary extracts and in the tissue samples in comparison
with authentic standards using UV signal at 285 nm.
Biochemical and hematological parameters: Blood
samples were taken by tail incision [11] at 7, 21 and 35 days
after the initiation of the study and by cardiac puncture, at the end
of the study, in heparinized tubes. Hematological parameters were
directly measured in the un-coagulated blood using an automatic
analyzer (Abacus Junior Vet, CVM S.L., Navarra, Spain) with
specific software to analyze rat blood parameters. The remaining
blood was centrifuged at 3000 g at room temperature for 15 min
in a Sigma 1–13 microcentrifuge (Braun Biotech. International,
Germany) to obtain plasma. Plasma samples were immediately
frozen at 280uC prior to analysis of biochemical parameters.
Levels of total glucose, total cholesterol, HDL-cholesterol (HDL-c),
LDL-cholesterol (LDL-c), triglycerides (TGs), and the hepatic
leakage enzymes: alkaline phosphatase (ALP), aspartate amino-
transferase (AST), and alanine aminotransferase (ALT) were
measured using an Olympus AU600 autoanalyzer (Olympus
Diagnostica, Hamburg, Germany). Insulin concentration was
quantified using an ultrasensitive rat insulin enzyme immunoassay
kit (Mercodia AB, Uppsala, Sweden) in a microplate reader
(TECAM infinite M200, Tecan Austria GmbH 5082, Grodig
Austria) with a 450 nm filter [12].
Hepatological examination: Sections of snap frozen liver
from each animal were embedded on the OCT cryostat
embedding compound (Tissue-Tek, Torrance, CA) and sectioned
(10 mm) with a cryostat (CM 3050S, Leica Microsystems GmbH).
Sections were stained using the oil red O method [13] and
observed under a light microscope (Nikon Eclipse 90i) at 206
magnification to detect neutral lipids. Images were captured using
a digital camera (Nikon Dxm 1200c) and the percentage of area
occupied by oil red O stained lipid droplets was calculated using
the Leica Qwin imaging software. Five fields per section were
analyzed.
Total TGs and cholesterol were analyzed in the liver following a
previously reported method [14]. Liver fragments (,100 mg) were
homogenized with 1 mL of RIPA buffer (50 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 0.5%
deoxycolic acid, 1% Triton X-100). Tissue extract (100 mL) was
then mixed with 1.6 mL of CHCl3:MeOH (2:1) for 16 h at 4uC
followed by addition of 200 mL of 0.6% NaCl and the solution was
centrifuged at 2.000 g for 20 min. The organic layer was removed
and dried using a SpeedVac concentrator. The resulting pellet was
dissolved in 100 mL phosphate buffered saline (PBS) containing
1% Triton X-100. TGs and cholesterol content were measured
using an Olympus AU600 autoanalyzer (Olympus Diagnostica,
Hamburg, Germany).
Enzymatic activity
On the day of use, the frozen organ or gut content samples were
quickly weighed (50–250 mg) and homogenized in ice-cold Tris-
HCl buffer (0.1 M) pH 8.0 (400–500 mL) using an Ultra Turrax
IKA-T10 basic tissue blender (Janke and Kunkel, Ika-Labortech-
nick, Germany). Homogenates were clarified by centrifugation at
20817 g for 10 min at 4uC and supernatants were collected for the
analysis of protein and enzyme activity. The total protein content
was measured by the DC colorimetric assay at 750 nm (BioRad,
Barcelona, Spain) based on a bovine serum albumin standard
curve. Lipase activity was tested by monitoring the cleavage of the
substrate p-nitrophenylbutyrate ($98%, Sigma-Aldrich S.A.,
Madrid, Spain) (PNPB) to release p-nitrophenol [15]. A stock
solution of PNPB (2.0 mM) was prepared in DMSO. The reaction
mixture (final volume, 1100 mL) contained the tissue supernatant
diluted to a suitable protein concentration in Tris-HCL buffer
(0.1 M) pH 8.0 and PNPB (25 mL, 2.0 mM) which was added to
start the reaction. After a brief mixing and autozero, the
absorbance at 400 nm was recorded for 5 min at 37uC using a
UV/visible spectrophotometer (Jasco V-630, Tokyo, Japan).
Background hydrolysis was measured by monitoring the auto-
hydrolysis of the substrate (no enzyme added) under the conditions
of the assay. The initial rate of absorbance increase minus the
background value was used as the measure of enzymatic activity.
The absorbance was converted to concentration of p-nitrophenol
using a standard curve. Activity values were expressed in
nanokatals (nkat)/g protein (1 U = 16.67 nkats) and are shown as
the mean value 6 SD of at least triplicate independent
measurements.
Inhibition of pancreatic lipase (lipase from porcine pancreas,
Type II, 100–400 units/mg protein, Sigma-Aldrich S.A., Madrid,
Spain) by CA and carnosol was also determined by the method
described above. CA or carnosol (5, 10 and 20 mg) were mixed
with 20 mL of pancreatic lipase (1 mg/mL) in 0.1 M Tris-HCl
buffer (pH 8) and 25 mL PNPB (2 mM) were added to start the
reaction (final volume, 1100 mL). Following incubation at 37uC for
5 min, absorbance was read at 400 nm.
Statistical analysis
Results are expressed as the mean value 6 SD. Differences
between groups were compared using an unpaired Student’s t test.
Results with a two-sided P-value ,0.05 were considered
statistically significant. P-values ,0.1 are also indicated.
Results
Characterization of the RE phenolic acid composition
using HPLC-DAD-MS/MS
HPLC-DAD-MS/MS analysis of the RE extract revealed that a
total of 15 phenolic compounds were present in the extract
distributed in three major categories: phenolic acids, diterpenes
and flavonoids. Figure 1 shows the chromatographic profile
(285 nm) of the RE. The compounds were characterized by their
retention times, UV-Vis and mass spectrum, and identified by
comparison with published data or commercial standards. A
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complete list with all the compounds identified in the RE is shown
in Table 1. Our data confirmed that the most abundant
compound was CA (38.961.7%). We were also able to quantify
the content of carnosol (6.560.1%) and methyl carnosate
(6.960.6%). The RE was mixed with the standard feed (0.5%,
w/w) and its stability was tested by monitoring the content of CA
using HPLC-DAD-MS/MS. The levels of CA in the chow
remained stable throughout the experimental period (90.0616.5%
of the initial quantity added).
Subchronic consumption of RE rich in CA was not toxic
to the animals
All animals survived the experimental procedure and no
abnormal signs or behavioral changes were observed throughout
the study. The results of the analysis of the hematological
parameters are shown in Table S1. Values were all within the
normal range and indicate that, in general, sustained consumption
of the RE enriched in CA was not toxic to the animals. We
observed a small but significant increase in the lymphocyte counts
in both lean and obese animals consuming the RE as well as an
increase in the mid-cell fraction in the obese animals supplement-
ed with RE. We also determined plasma levels of liver damage
markers in all the animals (Table S2 and Figures 2a to 2d). The
levels of AST were similar in the lean and the obese animals and
were not affected by the consumption of RE. The levels of ALP,
which were also similar in the lean and the obese animals, were
slightly increased after supplementation with the RE, significantly
in the lean animals (Figures 2a and 2b). ALT was slightly higher in
the obese animals than in the lean ones and supplementation with
RE caused a very small decrease in the plasma levels of this
enzyme, which was shown to be significant in the obese animals
(Figures 2c and 2d).
RE rich in CA reduced body weight and increases fecal
weight without affecting food intake in lean and obese
Zucker rats
Lean female Zucker rats were markedly smaller than their obese
counterparts throughout the experimental period (Figures 3a and
3b). In both groups of animals, supplementation with RE led to a
small but significant reduction in body weight which was
manifested earlier in the obese animals. Food intake was higher
in the obese animals than in their lean counterparts and was kept
constant during the supplementation period with no differences
observed between control animals (25.0962.69 and 14.8462.08 g
rat21 day21 for obese and lean rats, respectively) and their RE-
supplemented counterparts (23.9262.29 and 14.4461.94 g rat21
day21). There were no significant differences either in the
consumption of water between the control and treated groups
(23.165.4 and 23.061.7 mL rat21 day21 for obese rats, and
20.161.6 and 20.161.1 mL rat21 day21 for lean rats, respective-
ly). A small decrease in the weight gain throughout the
experimental procedure was reflected in a parallel decrease in
the food utility index (body weight gain divided by food
consumption) (Figures 3c and 3d) for both groups of animals but
no differences were found between control and the RE-supple-
mented groups. Fecal weight was also monitored during the
experiment and was found to be significantly higher (P,0.001) in
animals supplemented with RE than in the controls: 6.6460.37 vs.
5.4260.60 g rat21 day21 (fresh weight, f.w.) for obese animals,
and 3.6460.34 vs. 2.7760.20 g rat21 day21 (f.w.) for lean animals,
respectively. Rats in the RE supplemented groups had stools with
a softer consistency and a lighter color.
Figure 1. Main phenolic compounds present in the rosemary extract (RE). Chromatogram (285 nm) corresponding to the HPLC-DAD-MS
analysis of the RE extract. The structure and peak identification of carnosol (peak 10) and CA (carnosic acid, peak 14) are indicated. Peak numbers
correspond to each of the phenolic compounds identified in the extract and listed in Table 1.
doi:10.1371/journal.pone.0039773.g001
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Table 1. List of phenolic compounds identified in the rosemary extract (RE) by their retention times, UV-Vis and mass spectra and
by the use of standards.
Peak
Number Compound
Retention time
(min)
Absorbance
maxima (nm) [M–H]2
Major
fragments
detected (m/z) g/100 g
1 Caffeic acid hexoside 8.11 - 341 179, 161 -
2 Medioresinol 11.88 - 387 369, 207, 163 -
3 Isorhamnetin 3-O-hexoside 13.19 275, 340 477 462, 315, 300 -
4 Homoplantaginin 13.59 275, 334 461 446, 372, 299 -
5 Rosmarinic acid 13.88 285sh*, 332 359 223, 197, 179, 161 -
6 Rosmanol 17.21 289 345 301, 283 -
7 Cirsimaritin 17.39 274, 334 313 298, 283 -
8 Epirosmanol 17.68 288 345 329, 301, 283 -
9 Epiisorosmanol 18.26 - 345 301 -
10 Carnosol 20.22 284 329 285 6.560.1
11 Rosmadial 20.83 290 343 315, 299, 287 -
12 Epiisorosmanol ethyl ether 21.11 288 373 329, 283 -
13 49-Methoxytectochrysin 21.67 - 297 269, 282 -
14 Carnosic Acid 22.88 284 331 287 38.961.7
15 Methyl carnosate 24.89 282 345 331, 301, 286 6.960.6
*: shoulder
doi:10.1371/journal.pone.0039773.t001
Figure 2. Effects of the consumption of RE on plasma levels of the hepatic enzymes ALP and ALT (U/L) in Zucker female rats. Lean
(Le) and obese (Ob) rats fed the control diet (CT) or the diet supplemented with RE (RE). Data are presented as the mean value 6 SD (n = 7 for lean
animals and n= 5 for obese animals). * P,0.05 compared to their respective CT values.
doi:10.1371/journal.pone.0039773.g002
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RE rich in CA decreased serum levels of triglycerides and
cholesterol in lean Zucker rats but did not affect hepatic
lipids
A complete list with all the plasma biochemistry results is shown
in Table S2. A summary with the most significant changes is
presented in Figure 4. Lean Zucker female rats had lower levels of
TGs (Figure 4a and 4b), total cholesterol (Figures 4c and 4d),
LDL-c and HDL-c than their obese counterparts and TGs levels
were dramatically increased in the obese animals after the first
week of the study (Figure 4b). Supplementation with RE
significantly reduced the levels of serum TGs (,57%) and total
cholesterol (,25%) in the lean animals (Figures 4a and 4c).
Although the levels of these two parameters were also slightly
lower in the obese RE-supplemented group, differences were
neither significant nor consistent throughout the experimental
period (Figures 4b and 4d). A significant reduction of the levels of
LDL-c and HDL-c was also observed in lean rats consuming RE
at the end of the experimental supplementation (64 days). Plasma
glucose levels were in the normal range in all the animal groups
and were only found to be slightly (but not significantly) increased
in the obese rats at the end of the experimental procedure (Table
S2). No significant differences were found between the control and
the RE-supplemented animals indicating that the RE did not
affect the glucose homeostasis during the experimental procedure.
Notably, the consumption of the RE enriched in carnosic acid
resulted in a significant reduction in plasma insulin levels in the
lean rats (0.4760.27 vs. 0.1260.04 mg/L for control and treated
animals, respectively, P,0.01) whereas no significant differences
were detected between the control and treated obese rats
(3.6461.36 vs. 4.8962.24 mg/L, respectively).
To examine whether supplementation with RE had any effect
on the levels of lipids in the liver, we first measured neutral lipid
content in liver tissue using oil red O staining. At the end of the
experimental procedure, lipid droplets were markedly higher in
the obese animals than in the lean ones (data not shown).
Following exposure to the RE, no significant differences were
observed between control and treated rats. We further measured
the levels of TGs and total cholesterol in the liver and found that
consumption of the RE did not cause any change in the liver
content of TGs (23.467.7 mg/g vs. 24.868.2 mg/g for control
and supplemented obese animals, respectively; 16.964.3 mg/g vs.
17.367.5 mg/g for control and RE supplemented lean animals,
respectively) or in the content of total cholesterol (1.760.1 mg/g
vs. 1.760.2 mg/g for control and RE supplemented obese
animals, respectively; 2.060.1 mg/g vs. 2.060.5 mg/g for control
and supplemented lean animals, respectively).
RE rich in CA delivered a high content of intact CA and
carnosol to the stomach and significantly inhibited
gastric lipase activity
Table 2 shows the final organ and gut content weight in the lean
and obese animals as well as CA and carnosol content (mg/g. f.w.)
in these organs. Along the gastrointestinal tract the levels of
carnosol were always higher than those of CA. The greatest
content of carnosol and CA was found in the stomach with total
values (CA+carnosol) being higher in the obese animals than in the
lean ones: 91.2 m/g vs. 68.8 m/g. The levels of these two
Figure 3. Effects of the consumption of RE on body weight (g) and food utility index (FUI) in Zucker female rats. Lean (Le) and obese
(Ob) rats were fed the control diet (CT) or the diet supplemented with 0.05% of RE (RE) for 64 days. Data are presented as the mean value6 SD (n = 7
for lean animals and n=5 for obese animals). * P,0.05, ** P,0.01 compared to their respective CT values.
doi:10.1371/journal.pone.0039773.g003
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compounds were much lower in the duodenum and in the small
intestine where CA was not detected. In the liver, slightly higher
levels of CA were found compared to carnosol, whereas neither
compound could be detected in the pancreas. In addition,
substantial quantities of methyl carnosate were found in all the
gut content samples and in the liver.
The effects of consumption of RE on lipase activity were
determined by monitoring the activity against PNPB in the gut
content and organs from the different animal groups. The results
are presented in Figure 5. A significant inhibition of the enzyme
activity was detected in the stomach content of the obese and lean
rats supplemented with RE (approximately 80% inhibition, P,0.1
and 70% inhibition, P,0.05, respectively) (Figure 5a). The obese
rats also exhibited a smaller activity in the duodenum and small
intestine content when supplemented with the RE although
differences were not significant (Figures 5b and 5c). In contrast, we
found that the enzyme activity was significantly induced in the
liver of both the obese and lean rats fed with the diet supplemented
with RE (approximately100% increase, P,0.01 and 50%
increase, P,0.05, respectively) (Figure 5d). We also observed an
increase in the liver weight (Table 2). Similarly, the pancreas of the
RE-supplemented animals also exhibited a slightly higher activity
but values did not reach significance (Figure 5e).
We additionally tested the capacity of CA and carnosol to
inhibit the activity of porcine pancreatic lipase under the
conditions of our assay (Figure S1). We found that both
compounds exhibited a similar ability to inhibit the hydrolysis of
PNPB in a concentration dependent manner and reached around
65–70% inhibition at the highest concentration tested (18.2 mg/
mL).
Discussion
Long-term studies in animals exhibiting obesity are essential to
investigate anti-obesity treatments and, the choice of both the
animal model and sex are critical points that need to be
considered. In the present study we investigated the effects of
the daily consumption of a RE highly enriched in CA (40%) on
female Zucker lean and obese rats. Although, current worldwide
increases in obesity cannot be accounted for by changes in genetic
background, single gene mutation animal models such as the fa/fa
leptin signaling-deficient Zucker rat have been widely used as a
model of obesity and metabolic syndrome and provide a very good
model for insights into the mechanisms underlying the metabolic
deregulation associated to obesity [16]. In contrast to the most
generally accepted dietary-induced obesity models [17], the
Zucker obese phenotype becomes visible within a few weeks of
birth [18] and allows for more rapid evaluation of the effects of
anti-obesity compounds. Since males and females exhibit different
lipid metabolism [19], body fat distribution and percentage, as
well as different levels and sensitivity to key metabolic hormones
such as leptin or insulin [17], the choice of sex is also an important
issue in studies looking at the effects of anti-obesity drugs. Sexual
dimorphism in lipid metabolism is the result of hormone action
(estrogens and estrogen receptors, ER) [20] and of other complex
sex-specific modulators that remain to be elucidated [21]. After
reviewing the literature for studies looking at the anti-obesity
effects of carnosic acid or rosemary extract [6–9,22] (see Table 3 of
the manuscript) we noticed that the lipid-lowering and body
weight-reducing effects of these products had only been tested and
reported in male mice and male rats and thus, we carried out our
studies in female rats to determine whether these effects were also
Figure 4. Effects of the consumption of RE on plasma levels of TGs and total cholesterol (mmol/L) in Zucker female rats. Lean (Le) and
obese (Ob) rats fed the control diet (CT) or the diet supplemented with RE (RE). Data are presented as the mean value 6 SD (n = 7 for lean animals
and n= 5 for obese animals). ** P,0.01, *** P,0.001 compared to their respective CT values.
doi:10.1371/journal.pone.0039773.g004
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manifested in females. Of note, carnosol, found at significant levels
in the RE and in the gastrointestinal tract and liver after the
consumption of the RE, has been reported to interact with ER-
alpha and functions as an antagonist [23]. It is then plausible that
this molecule may interact with ER in vivo and cause different
modulatory effects in female and males.
Our results show that the consumption of the RE rich in
carnosic acid causes a moderate but significant reduction in body
weight (approximately 15%) both in the female obese rats and in
their lean littermates without affecting the food intake and
corroborates with earlier published results in male mice [6–
9,22]. Our study and others [6–9] also show that these effects were
manifested shortly after the start of supplementation with RE or
CA (between 10 and 15 days) and were independent of the dose
administered or the animal model studied (either diet-induced
obesity or genetic models). In this study, rats were fed a standard
chow supplemented with 0.5% of RE and thus the effective
administered doses ranged approximately from: i) 584 mg RE/Kg
body weight (b.w.) day21 (233 mg CA/Kg b.w. day21) at the start
of the study to 348 mg RE/Kg b.w. day21 (138 mg CA/Kg b.w.
day21) after 64 days of consumption of the extract for the lean rats
and, ii) 700 mg RE/Kg b.w. day21 (280 mg CA/Kg b.w. day21)
to 544 mg RE/Kg b.w. day21 (218 mg CA/Kg b.w. day21) for
the obese animals. The human equivalent doses (HED) [24] would
range approximately between 50 and 100 mg of RE/Kg b.w
day21 (equivalent to 20 to 40 mg of CA/Kg b.w. day21). These
doses would contain a small amount of carnosol (3 to 6 mg/Kg
b.w. day21). These quantities of CA+carnosol are well above those
estimated to be attained through the diet, i.e. 0.04–0.11 mg/Kg
b.w. day21 [25] and could only be achieved through the
consumption of nutraceuticals or supplements rich in these
compounds for which toxicity has not been fully evaluated.
Regarding the toxic effect of long-term consumption of high
doses of REs or CA plus carnosol, the European Food Safety
Authority has established that the non-observed-adverse-effects-
level (NOAEL) values are in the range of 180 to 400 mg extract/
Kg b.w. day21 (equivalent to ,20–60 mg of CA+carnosol/Kg
b.w. day21) based on 90-days feeding studies in rats [25]. It has
also been reported that an acute single dose of 2000 mg of RE/Kg
b.w. (containing up to 48% CA and 11% of carnosol) was not toxic
to Wistar rats as it did not affect hematological and clinical
parameters, body and organ weight, or gross or histological
characteristics [26]. In the present study, sub-chronic consumption
of the aforementioned doses of RE (containing 40% CA and 6.5%
carnosol) for 64 days did not substantially affect any of the
hematological parameters tested indicating a low toxicity of the
extract. This was further supported by the small changes observed
in the levels of the hepatic enzymes. We did observe, however, a
small increase in the WBCs, primarily in the lymphocytes.
Although an increase in these cells might be considered a sign of
inflammatory response to infection, the increased values were still
within the normal range [26] and they may also suggest a small
immunostimulatory effect like that reported for other plant
medicinal extracts [27,28]. A systemic immunomodulation may
be a consequence of a modulatory effect on the gut-associated
immune function partially associated with activation and modifi-
Table 2. Final body weight, organ and gut content weight for lean (Le) and obese (Ob) female Zucker rats fed the control diet (CT)
or the diet supplemented with RE enriched in CA (40%).
CTLe RELe CTOb REOb
Stomach content Weight (g)a 2.7760.83b 2.4760.77 4.1461.05 6.2861.95
CA (mg/g) N.D. 24.79617.67 N.D. 28.09615.45
Carnosol (mg/g) N.D. 43.97611.22 N.D. 63.09612.08
Methyl carnosate (mg/g) N.D. 11.4561.59 N.D. 17.2663.66
Duodenum content Weight (g) 0.4460.09 0.4860.11 0.5160.08 0.5460.15
CA (mg/g) N.D. 3.3268.79 N.D. N.D.
Carnosol (mg/g) N.D. 5.54612.55 N.D. 8.3865.68
Methyl carnosate (mg/g) N.D. 28.03616.48 N.D. 21.46611.71
Small intestinec
content
Weight (g) 2.4460.66 2.7060.25 3.1060.43 3.3060.86
CA (mg/g) N.D. N.D. N.D. N.D.
Carnosol (mg/g) N.D. 12.7862.92 N.D. 14.5562.52
Methyl carnosate (mg/g) N.D. 12.2761.29 N.D. 12.8860.58
Liver Weight (g) 8.5360.71 9.2160.77 14.8061.70 17.0261.21
CA (mg/g) N.D. 4.1561.04 N.D. 3.4261.83
Carnosol (mg/g) N.D. 1.6360.35 N.D. 2.5761.10
Methyl carnosate (mg/g) N.D. 21.8463.71 N.D. 29.1469.52
Pancreas Weight (g) 0.6660.09 0.6860.09 0.6460.11 0.5860.20
CA (mg/g) N.D. N.D. N.D. N.D.
Carnosol (mg/g) N.D. N.D. N.D. N.D.
Methyl carnosate (mg/g) N.D. N.D. N.D. N.D.
The content of CA, carnosol and methyl carnosate detected in these samples is also indicated.
a: Organs and gut content were collected and weighed at the end of the experimental procedure.
b: Values are the mean 6 SD (n = 7 for lean animals and n = 5 for obese animals) and are expressed as g of fresh weight (f.w.);
c: jejunum+ileum; N.D.: Not detected.
doi:10.1371/journal.pone.0039773.t002
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cation of the number of Peyer’s patches [29]. In support of a
putative RE immunostimulatory effect for a RE enriched in CA,
we counted the Peyer’s patches in the intestine of the lean and
obese rats and found that numbers were slightly higher (although
not significantly) in the groups supplemented with RE than in
control groups (data not shown).
Another important effect attributed to CA or RE in male
animals is the reduction of the levels of TGs and cholesterol as
summarized in Table 3. The consumption of CA appears to
reduce TGs in plasma and this effect seems to be more noticeable
at a higher dose. CA also seems to be able to reduce the levels of
TGs in the liver. However, studies evaluating the effects of the
consumption of RE containing CA have yielded less consistent
results. Discrepancies may be due to variability in the composition
of the extract and the doses of the RE used, or to the animal
models employed. In our study, body weight was reduced in the
lean and obese animals indicating that both phenotypes were
responding to treatment with the RE. However, the decrease in
the levels of TG and cholesterol was only significant in the lean
female rats. These differences may be attributed to the altered
lipolytic responsiveness in the obese Zucker rats that can be
refractory to nutritional and pharmacological interventions [30].
The obese animals have a well-developed hyperlipidemia with
rather high serum lipid levels where it is more difficult to exert a
regulatory effect. Recently, it has been suggested that the lack of a
functional leptin receptor in the obese fa/fa Zucker rats contributes
to the impairment of the regulation of fat metabolism and may
worsen or slow the capacity of these animals to mobilize lipids
[31]. In contrast to the obese animals, the lean Zucker rats are
considered normal rats, sensitive to insulin, normotensive and with
a normal glucose tolerance and lipid profile [16]. The levels of key
metabolic regulators are also different in the lean animals as
Figure 5. Effects of the consumption of RE on lipase activity in Zucker female rats. Lean (Le) and obese (Ob) rats fed the control diet (CT) or
the diet supplemented with RE (RE). Activity (expressed in nkats/g) was measured as the hydrolysis of PNPB in a) stomach content, b) duodenum
content, c) small intestine (jejunum+ileum) content, d) liver and e) pancreas. Data are presented as the mean value 6 SD (n = 7 for lean animals and
n= 5 for obese animals). # P,0.1, * P,0.05 and ** P,0.01 compared to their respective CT values.
doi:10.1371/journal.pone.0039773.g005
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compared to the obese ones [32]. These differences may account
for their different responses to dietary factors, especially those that
affect the lipid metabolism and therefore it is not unusual to find
differences between the responses of lean and obese Zucker rats
after exposure to anti-obesity drugs. Like this, a fermented-milk
product caused a significant decrease in body weight, mesenteric
fat, mesenteric adipocyte size, and HDL levels in lean rats but not
in the obese animals [33] or oral fibrate administration
significantly lowered serum lipids in lean animals only [34].
Zucker obese animals are not always resistant to antiobesity
therapies and, for example, treatment with oleoylethanolamide
decreased body weight more markedly in lean Zucker rats than in
their obese counterparts but the TG levels were not affected in the
lean animals and were significantly reduced in the obese animals
[35,36]. With regard to the insulin levels, our data are in good
agreement with those reported by Sa´nchez et al. [12] for female
lean and obese control rats. These authors also reported a
reduction in the levels of plasma insulin in Zucker rats fed a fiber-
enriched diet. A link between dietary fiber, lower insulin levels and
decreased body weight has been already described [37]. Insulin is
also a very important regulator of plasma TG homeostasis by
upregulating TG synthesis and suppressing TG hepatic secretion
[38] with usually a direct correlation between TGs and insulin
levels. Our results show that the observed reduction in the levels of
TG in the lean Zucker rats was concomitant with a reduction in
the serum insulin levels.
The reduction in body weight and lipid levels observed after the
consumption of RE or CA has been suggested to be caused by a
reduction in the absorption of dietary fat further supported by an
increase in fecal fat excretion [6,7]. Although we did not measure
the fat content in the feces in our study, we did find a significant
increase in the fecal mass as well as a paler color of the feces in the
RE-supplemented animals consistent with a higher content in fat.
Since RE, CA and also carnosol are able to inhibit the activity of
pancreatic lipase in vitro, the reduction in body weight and lipid
levels may be mediated through the inhibition of pancreatic lipase
activity in the gastrointestinal tract [6,7,9]. To determine if this
lipase inhibition may occur in vivo, it is important to evaluate: i)
whether these compounds may reach sufficient concentrations in
the gastrointestinal tract in their intact molecular form and if so, ii)
whether they are able to inhibit the enzyme activity in the gut. In
vitro studies have shown that under simulated conditions of the
gastric digestion (pH = 2.0, 37uC, 1 h) the concentration of CA,
carnosol and also of methyl carnosate is diminished. This decrease
is even greater under simulated conditions of the intestinal
digestion (pH = 7.5, 37uC, 1 h) and some conversion of CA into
carnosol has been reported [39]. However, these conditions may
differ from those observed in vivo where after feeding the pH may
be around 3.9 in the stomach and below 6.6 in the intestine of rats
[40] and thus, in vivo results may be different. In rats, an intra-
gastric acute dose of CA (90 mg/Kg) yielded high quantities of CA
in the stomach (maximum concentration detected was approxi-
mately 300 mg/g) whereas, in the intestine, the quantity of CA was
10-fold lower (30 mg/g). Measurements of carnosol content were
not reported in this study [41]. We have quantified the levels of
CA, carnosol and methyl carnosate present in the gastrointestinal
tract of the Zucker rats supplemented with RE and found the
highest levels of CA and carnosol in the stomach. Along the
gastrointestinal tract, we also found that the levels of CA were
always lower than those of carnosol. These results support some in
vivo conversion of one compound to another but it may also be due
to a faster absorption of CA than of carnosol. Recently, it has been
reported that CA can be detected in the plasma of rats 7 min after
oral dosage of the compound [42]. Interestingly, of the three
compounds detected, the most abundant in the jejunum, ileum,
and liver, was the methylated derivative of CA. Although this
metabolite may originate partially from the compound already
present in the RE, our data suggest an in vivo methylation of CA
likely due to the action of cathecol-O-methyl transferases
(COMTs) present in the intestine and liver [43].
Our data also showed that the highest and most significant
inhibition of lipase activity (70–80%) was detected in the stomach
of the RE-supplemented animals. We have also shown that in vitro
inhibition of lipase activity by CA and carnosol was around 65–
70% for a test compound concentration of ,18 mg/mL. Based on
the quantities of CA and carnosol found in the stomach of the rats
and given an estimated stomach volume of 3.5 mL [40], the
concentrations of these compounds in the stomach of the Zucker
rats may reach values as high as ,18 mg/mL and ,50 mg/mL of
CA for the lean and obese animals, respectively, whereas carnosol
may be even higher, ,30 mg/mL and ,100 mg/mL. These
concentrations substantiate the pronounced lipase activity inhibi-
tion observed in the stomach content. The main lipase activity in
the stomach is due to gastric lipase (GL) which is an active and
stable lipolytic enzyme that initiates the gastrointestinal digestion
of dietary fat [44]. GL continues its activity in the duodenum
where it acts synergistically with pancreatic lipases and may be
able to release 10–40% of dietary triglyceride acyl chains [2].
Table 3. Comparative results of some of the reported effects of the consumption of RE or CA on body weight and lipid changes.
Animal model
Tested
material Dose and duration Body weight Serum TGs
Serum
cholesterol Liver TGs Reference
High fat-fed male mice CA 20 mg/Kg,
14 days
Q,24% Q,30% N.D. N.D. [9]
Ob/ob male mice CA 60 mg/Kg,
35 days
Q,20% Q,60% Q,24% Q,47% [8]
Male rats RE 250 mg/Kg, 500 mg/Kg,
63 days
No significant
effect
No significant
effect
No significant
effect
N.D. [21]
High fat -fed male mice RE 200 mg/Kg (<5 mg CA/Kg and
11.2 mg CAR/Kg),
50 days
Q,64% No significant
effect
No significant
effect
Q,39% [6]
High fat -fed male mice RE 600 mg/Kg (<120 mg CA/Kg),
112 days
Q,25% No significant
effect
Q,18% N.D. [7]
RE: Rosemary extract; CA: carnosic acid; N.D.: Not determined.
doi:10.1371/journal.pone.0039773.t003
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Therefore, inhibition of GL may contribute greatly to reduce the
absorption of fat. Other dietary phenolic compounds, such as
cocoa procyanidins [15], tea polyphenols [45] or hydroxytytrosol
[46] have also been reported to inhibit pancreatic lipase activity in
vitro. We speculate that they may also be able to inhibit gastric
lipase and thus, regular consumption of high quantities of phenolic
compounds through the diet or dietary supplements may supply
sufficient quantities into the stomach, where they remain
structurally unmodified [47], and efficiently reduce the digestion
and subsequent absorption of fat. Further research looking at the
inhibition of enzymatic fat digestion in the stomach by RE and its
main phenolic components is warranted.
Orlistat is a well-known pancreatic lipase inhibitor which may
cause weight loss of up to 10% [48]. Low doses of orlistat (10–
20 mg/Kg/day) can also decrease serum lipid levels and modulate
food intake although results show some variability [49–52]. In our
study, the RE rich in carnosic acid, at oral doses between 350 and
700 mg extract/Kg/day (140 to 280 mg carnosic/Kg/day),
caused a significant reduction in body weight (,15%) without
affecting food intake. A significant reduction in TG and cholesterol
was also shown in the lean animals. These results indicate a good
efficiency of the extract as compared to that of orlistat. Although
the doses of RE were higher than those of the drug, we need to
bear in mind that the extract include many other active or inactive
components and, consequently, the inhibitory potency of the
extract may result diluted. Like this, in vitro testing of the lipase
activity inhibition clearly shows that orlistat is more potent than a
RE containing 20% carnosic acid [7]. However, in an acute test
carried out in oil-loaded male mice, the same oral doses of pure
carnosic acid and orlistat (5 to 20 mg per Kg) caused a similar
reduction in serum TG in a maximum period of 6 h [9] indicating
a similar efficiency between orlistat and carnosic acid.
In addition, in this study we also found that the livers of the
animals supplemented with RE had a higher weight and a
significant induction of the enzymatic activity. These results are in
agreement with previous data reporting liver enlargement and
enzyme induction as a response to exposure to rosemary extracts
[53,54]. However, the levels of CA and carnosol detected in the
liver were much lower than those in the gut which suggests that
other derived metabolites may be responsible for the effects in this
organ. Further ongoing research is being carried out at our lab to i)
identify other CA and carnosol metabolites present in the liver and
ii) to determine gene and protein changes induced in the liver of
the supplemented animals that may contribute to explain the
modulation of the plasma lipid levels caused by RE consumption
as well as the differences between lean and obese animals. In
conclusion, our results show a significant inhibition of gastric lipase
in the stomach of Zucker rats consuming RE enriched in CA
which may cause a moderate reduction of fat absorption consistent
with the observed reduction in weight gain and triglycerides and
cholesterol levels. Our data suggest that long-term consumption of
rosemary extracts rich in CA may be beneficial for maintaining a
normal lipid profile and a lower weight.
Supporting Information
Figure S1 In vitro inhibition of pancreatic lipase by
carnosic acid and carnosol. Carnosic acid or carnosol (5, 10
and 20 mg) were mixed with 20 mL of porcine pancreatic lipase
(Type II, 100–400 units/mg protein; 1 mg/mL) in 0.1 M Tris-
HCl buffer (pH 8) and 25 mL p-nitrophenylbutyrate (PNPB;
2 mM) were added to start the reaction (final volume, 1100 mL).
Following incubation at 37uC for 5 min, absorbance was read at
400 nm. Values are presented as % of inhibition respect to control
values in the absence of test compound. Measurements were done
in triplicate and results are presented as mean values 6 SD.
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Table S1 Hematological parameters in female Zucker
rats.
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Table S2 Biochemical parameters in female Zucker
rats.
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